Oscar Health, Inc. (OSCR)

Oscar Health Stock Forecast

Stock Price Forecast

The 6 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $15.58, which forecasts a 4.56% increase in the stock price over the next year. The lowest target is $10 and the highest is $23.

Price Target: $15.58 (+4.56%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$10	$15.58	$17	$23
Change	-32.71%	+4.85%	+14.40%	+54.78%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	4	3	3	3	1	1
Hold	2	3	3	3	2	1
Sell	2	2	2	2	2	4
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Baxter Wells Fargo	Wells Fargo	Hold → Sell Downgrades $16 → $10	Hold → Sell	Downgrades	$16 → $10	-32.71%	Jul 11, 2025
Andrew Mok Barclays	Barclays	Sell Initiates $17	Sell	Initiates	$17	+14.40%	Jul 2, 2025
Jessica Tassan Piper Sandler	Piper Sandler	Buy Maintains $25 → $18	Buy	Maintains	$25 → $18	+21.13%	Jun 9, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Buy → Hold Downgrades $20 → $16	Buy → Hold	Downgrades	$20 → $16	+7.67%	Mar 13, 2025
David Windley Jefferies	Jefferies	Sell Initiates $12	Sell	Initiates	$12	-19.25%	Dec 10, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

11.55B

Increased by 25.81%

from 9.18B

Revenue Next Year

11.62B

Increased by 0.60%

from 11.55B

EPS This Year

0.70

Increased by 603.80%

from 0.10

EPS Next Year

0.90

Increased by 28.36%

from 0.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	390.99M	1.89B	3.96B	5.86B	9.18B	11.55B	11.62B	13.34B
Revenue Growth	-17.79%	384.43%	109.27%	47.92%	56.54%	25.81%	0.60%	14.81%
EPS	-14.16	-3.20	-2.85	-1.22	0.10	0.70	0.90	1.67
EPS Growth	-	-	-	-	-	603.80%	28.36%	85.16%
Forward PE	-	-	-	-	-	21.11	16.45	8.88
No. Analysts	-	-	-	-	-	11	11	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	12.5B	13.3B	14.9B
Avg	11.5B	11.6B	13.3B
Low	10.8B	10.4B	11.4B

Revenue Growth

Revenue Growth	2025	2026	2027
High	36.0%	15.4%	28.7%
Avg	25.8%	0.6%	14.8%
Low	18.0%	-9.8%	-2.0%

EPS Forecast

EPS	2025	2026	2027
High	0.92	1.97	2.36
Avg	0.70	0.90	1.67
Low	0.58	0.09	0.54

EPS Growth

EPS Growth	2025	2026	2027
High	824.0%	180.5%	161.5%
Avg	603.8%	28.4%	85.2%
Low	478.2%	-87.5%	-40.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.